TW201107478A - Photosynthetic microorganisms enriched in selenium using selenohydroxy acid compounds, uses thereof in nutrition, cosmetics and pharmacy - Google Patents

Photosynthetic microorganisms enriched in selenium using selenohydroxy acid compounds, uses thereof in nutrition, cosmetics and pharmacy Download PDF

Info

Publication number
TW201107478A
TW201107478A TW099119944A TW99119944A TW201107478A TW 201107478 A TW201107478 A TW 201107478A TW 099119944 A TW099119944 A TW 099119944A TW 99119944 A TW99119944 A TW 99119944A TW 201107478 A TW201107478 A TW 201107478A
Authority
TW
Taiwan
Prior art keywords
selenium
group
mass
rich
microorganism
Prior art date
Application number
TW099119944A
Other languages
Chinese (zh)
Other versions
TWI495725B (en
Inventor
Bernard Kudla
Baene Frederic De
Marc Lange
Original Assignee
Eco Solution
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/FR2009/001044 external-priority patent/WO2010023384A1/en
Application filed by Eco Solution filed Critical Eco Solution
Publication of TW201107478A publication Critical patent/TW201107478A/en
Application granted granted Critical
Publication of TWI495725B publication Critical patent/TWI495725B/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to the enrichment of photosynthetic microorganisms in organic selenium using selenohydroxy acid compounds, in particular 2-hydroxy-4-methylselenobutanoic acid, in D or L form, or an enantiomer, salt or ester or amide derivative of these compounds, and also to the use of the microorganisms thus enriched in animal or human nutrition, in cosmetics or in pharmacy.

Description

201107478 六、發明說明: 【發明所屬之技術領域】 本發明係關於使用D或L型之硒羥酸化合物,特別是2_ 羥基-4-甲基硒丁酸或這些化合物之對映體、鹽或醋或_胺 衍生物使光合微生物富含有機硒之方法,及關於因而增進 營養價値之該光合微生物在動物或人類營養品、化妝品或 藥物的用途。 〇 【先前技術】 硒特別是人類及哺乳類的必要微量營養品( W end el 5 A .; Phosphorus, Sul fur Silicon Rel at E1 em . 3 1 992, 67, 1 -4, 404-41 5 )。特別地,彼以L( + )-硒半胱胺酸或 L( + )-硒甲硫胺酸形式(Muller, S. et al., Arch. Microbiol·, 1 997,168,421)參與硒蛋白質類諸如穀胱甘 肽過氧化酶、硫氧化還原蛋白還原酶及硒蛋白質P的生物 ◎合成。 已報告在人體內之硒缺乏症,特別是在長時間接受非 經腸胃餵食的病患情況中(Von Stockhausen,H.B.,Biol. Trace Elem. Res.,1 98 8, 1 5:1 47- 1 5 5 )。每日補充 200微克 硒對於具有平均體重之成年人被認爲是安全的且合適的( Schrauzer, G.N., J. Am. Col. Nutr., 200 1, 20:1 -1 4 )。 硒在自然界以二種形式(有機及無機)被發現。 無機化合物最普遍是鹽類諸如亞硒酸鈉或硒酸鹽。這 些化合物對人類及大部分之動物是極具毒性的。 -5- 201107478 有機化合物(有機硒化合物)在活組織中特別是以胺 基酸L( + )-硒甲硫胺酸、L( + )-甲基硒半胱胺酸及L( + )-硒半 胱胺酸爲代表。 L( + )_硒甲硫胺酸是人體內及動物體內有機硒之主要來 源。然而,人類及動物對此種胺基酸是非自營的,而僅能 經由飲食獲得。 因此硒理想上應以此有機形式被倂入用於治療或預防 硒缺乏症的食品補充物中。 因此已可顯示:飮食補充L( + )-硒甲硫胺酸比攝取亞硒 酸鈉形式者之毒性低很多的且提供較佳之生物利用性( Mony, M. C. et al., J. of Trace Elem. Exp. Med., 2000, 1 3 :367-380)= 現今,除了使用無機硒(主要是亞硒酸鈉形式)及硒 甲硫胺酸作爲基質者以外,活組織對硒吸收之代謝途徑是 未知的。 有機硒之合適的供應可在較高等植物(特別是小麥、 玉米、大豆)發現,其中多於80%之硒是由L( + )-硒甲硫胺 酸構成(Schrauzer,G.N.,J. Am. Coll. Nutrit.,200 1, 20(1) : 1-4 )。然而,在這些植物中硒濃度是不足的,以 致不能容易地且較不昂貴地製造食品添加劑。 用於獲得富含硒甲硫胺酸之組成物所發展的方法之一 係由使用無機硒以使某些微生物富含有機硒的方式組成。 一旦富含有機硒,這些微生物可被用來作爲製備食品或化 妝產品之原料。 -6 - 201107478 很多刊物描述例如富含硒之酵母及更特別地啤酒酵母 之製備(Oh Tae-Kwang et al·,0 6 · 2 6.1 9 9 5 之 KR9 5 0 0 0 6 9 5 0 專利),以供使用彼本身之目的或將彼倂入食品組成物之 目的(Moesgaard S. et. al·,09.16.2003 之 DK 200200408 專 利);或者供獲得富含硒之衍生產物例如富含硒之麵包( Wang Boaquan, 0 8 · 1 6 · 2 0 0 6 之 C N 1817143 專利)、奶類( Jeng Chang-Yi,1 2 1 1 · 2 0 0 3 之 T W 5 6 5 4 3 2 專利)、蛋(Cui O Li et al. ,03.07.2007 之 CN1 302723C 專利)、巧克力(In Gyeong Suk et al., 1 1.0 8.2 0 04 之 KR2 0 0 4 0 1 0 1 1 4 5 專利)或 啤酒(Jakovleva L.G. et al., 0 7.2 7 · 2 0 0 3 之 RU 2 2 0 9 2 3 7 專利 )之目的。在健康食品中,也已建議含有富含硒之酵母的 製劑以供懷孕婦女之用(Wang Weiyi, 05.3 1.2006之 CN 1 778 1 99 ),或供改良低血糖病患之腸的微環境(Li Tao Zhao, 08.02.2006 之 CN1810161專利)。在皮膚用化妝 品領域中,含有富含硒之酵母的組成物已經發展以供減少 ^ 頭髮受損之目的(KasikHeinz,06.2 1.2000之DE 1 98 5 8670 )或預防光老化(Kawai Norihisa el al.,11.14.1995 之 JP07300409專利)。含有富含硒之酵母的醫藥製劑已經用 在預防及治療發炎病況諸如與糖尿病相關之視網膜病變( Crary Ely J·,06.1 7.1 997 之 US56239482 專利),或心血管 之發炎病況(Nagy P.L. el al.,09.28.1 992 之 HUT060436 專 利)。 細菌及更特別是益生菌本身已是硒富含物之主體( Calomme M. et al., Biol. Trace Elem. Res., 1 995, 47, 3 79- 201107478 3 83 )。已描述嗜酸乳酸桿菌以及洛德(reuteri )乳酸 菌、費仁多(ferintoshensis)乳酸桿菌、巴曲(buchn )/帕拉巴曲(parabuchneri )乳酸桿菌(Andreoni V_ al·,US 02 58 964專利)作爲富含硒之食品補充物。已經 備用於強化免疫系統及抗病目的之由酵母及乳酸桿菌組 之益生菌混合物(Huang Kehe Qin, 1 1.08.2006 CN 1 283 1 7 1 C專利)。 然而,在所有這些製劑中,富含硒之微生物係僅由 機硒製備。因此,最普遍被使用之硒來源係由在微生物 養介質中安定化的亞硒酸鈉或硒酸鈉組成。雖然已合成 滿意量之可被人體消化吸收的有機硒,由此富含硒之微 物常具有高殘餘濃度的未轉化無機硒,其經證實對食用 之個人有危險性。 在以WO 2006/008 1 90公開的先前申請案中,新穎之 羥酸型的有機化合物已經描述能作爲在人類及動物體內 成L( + )-硒甲硫胺酸的先質。 令人驚訝地,申請人已注意到:硒羥酸型有機化合 ,諸如在WO 2006/008 1 90申請案中描述者,可倂入使多 光合微生物富含有機硒的培養介質中。所得結果已揭示 這些化合物能極有效率地使此種微生物特別富含L( + )-硒 硫胺酸,而其產率等於或甚至高於使用一般所用之無機 合物所得者。 因此已顯明:使用硒羥酸型有機化合物使光合微生 富含有機硒之方法能製造不含無機硒之有機硒’且也能 桿 ΪΓ1 et 製 成 之 Μ 培 出 生 彼 硒 合 物 種 甲 化 物 解 -8 - 201107478 決與先前技藝方法相關之毒性問題。 由此富含硒之光合微生物可以直接用在預防或治療硒 缺乏症的食品交易中,特別適用於製造藥用、營養用或化 妝用產品及組成物。 【發明內容】 本申請案係關於光合微生物,亦即按照光能量來源生 〇 長之微生物的獲得。 “微生物”一詞企圖指明屬於以下範疇之一的任何活的 單細胞有機體:單蟲類、單細胞生物、黴菌、或原蟲門, 彼具有微觀或超微觀尺寸之真核或原核的細胞結構且彼具 有代謝及複製潛能。該等單細胞微生物可以與纖絲或生物 薄膜之形成有關。 較佳地,依本發明之光合微生物是真核微藻類,更佳 是綠球藻屬之綠藻;或原核微藻類,諸如藍菌,較佳是螺 〇 旋藻屬或節旋藻屬(螺旋藻)。後者對精於此技藝者是習 知用來作爲食品補充物的,特別是在發展中國家。 “有機硒”一詞意圖指明一種分子集合,其含有一種具 有至少一個硒原子於其化學結構中且能藉由活組織產生之 化合物’特別是諸如硒甲硫胺酸、甲基硒半胱胺酸及半胱 胺酸等胺基酸,或含彼之肽類或蛋白質。由此富含硒之光 合微生物本身可被使用或作爲食品添加劑。 彼可以例如被脫水以形成一種安定粉末,該粉末能倂 入作爲製備轉化產物用之基質的組成物中,但也可以活的 -9 - 201107478 方式被用來作爲食品轉化方法中之益生菌,以供獲得例如 發酵奶或飮品之目的。 本發明之標的因此是一種使光合微生物富含硒甲硫胺 酸及/或硒半胱胺酸之新穎方法,其特徵在於該光合微生 物在包含硒羥酸型化合物之培養介質中培養。 較佳地,該硒羥酸型化合物是通式(I)之化合物、 或其先質、鹽或酯或醯胺衍生物:201107478 VI. INSTRUCTIONS OF THE INVENTION: TECHNICAL FIELD OF THE INVENTION The present invention relates to the use of a selenic acid compound of the D or L type, in particular 2 hydroxy-4-methyl seletonic acid or the enantiomers, salts or The use of vinegar or _amine derivatives to enrich photosynthetic microorganisms with organic selenium, and the use of such photosynthetic microorganisms in animal or human nutrition, cosmetics or pharmaceuticals to thereby increase nutritional value. 〇 [Prior Art] Selenium is especially a necessary micronutrient for humans and mammals (Wend el 5 A .; Phosphorus, Sul fur Silicon Rel at E1 em. 3 1 992, 67, 1 -4, 404-41 5 ). In particular, he participates in selenium in the form of L(+)-selenocysteine or L(+)-selenomethionine (Muller, S. et al., Arch. Microbiol, 1, 997, 168, 421). Bio-synthesis of proteins such as glutathione peroxidase, thioredoxin reductase, and selenoprotein P. Selenium deficiency has been reported in humans, especially in patients who have been receiving parenteral feeding for a long time (Von Stockhausen, HB, Biol. Trace Elem. Res., 1 98 8, 1 5:1 47-1 5 5 ). Daily supplementation of 200 micrograms Selenium is considered safe and suitable for adults with average body weight (Schrauzer, G.N., J. Am. Col. Nutr., 200 1, 20:1 -1 4 ). Selenium is found in nature in two forms (organic and inorganic). Inorganic compounds are most commonly salts such as sodium selenite or selenate. These compounds are extremely toxic to humans and most animals. -5- 201107478 Organic compounds (organic selenium compounds) in living tissues, especially amino acid L( + )-selenyl methionine, L( + )-methyl selenocysteine and L( + )- Selenium cysteine is representative. L( + )_selen methionine is the main source of organic selenium in humans and animals. However, humans and animals are not self-supporting for this kind of amino acid, but can only be obtained through diet. Therefore, selenium should ideally be incorporated into food supplements for the treatment or prevention of selenium deficiency in this organic form. Therefore, it has been shown that the supplementation of L(+)-selen methionine is much less toxic than the intake of sodium selenite and provides better bioavailability (Mony, MC et al., J. of Trace) Elem. Exp. Med., 2000, 1 3 :367-380)= Nowadays, in addition to the use of inorganic selenium (mainly in the form of sodium selenite) and selenium methionine as matrix, the metabolism of selenium absorption by living tissue The route is unknown. A suitable supply of organic selenium can be found in higher plants (especially wheat, corn, soybeans), where more than 80% of the selenium is composed of L(+)-selen thiomethionine (Schrauzer, GN, J. Am) Coll. Nutrit., 200 1, 20(1): 1-4). However, the concentration of selenium in these plants is insufficient, so that food additives cannot be easily and inexpensively manufactured. One of the methods developed for obtaining a composition rich in selenium methionine consists of using inorganic selenium to make certain microorganisms rich in organic selenium. Once enriched with organic selenium, these microorganisms can be used as a raw material for the preparation of food or cosmetic products. -6 - 201107478 Many publications describe the preparation of, for example, selenium-rich yeast and more particularly brewer's yeast (Oh Tae-Kwang et al., 0 6 · 6.1 9 9 5 KR9 5 0 0 0 6 9 5 patent) For the purpose of using itself or for the purpose of incorporating it into a food composition (Moesgaard S. et. al., DK 200200408 patent of 09.16.2003); or for obtaining a selenium-rich derivative product such as selenium-rich Bread (Wang Boaquan, CN 817143 patent of 0 8 · 1 6 · 2 0 0 6), milk (Jeng Chang-Yi, TW 5 6 5 4 3 2 patent of 1 2 1 1 · 2 0 0 3), egg (Cui O Li et al., CN1 302723C patent of 03.07.2007), chocolate (In Gyeong Suk et al., 1 1.0 8.2 0 04 KR2 0 0 4 0 1 0 1 1 4 5 patent) or beer (Jakovleva LG) Et al., 0 7.2 7 · 2 0 0 3 RU 2 2 0 9 2 3 7 Patent). In healthy foods, preparations containing selenium-rich yeast have also been proposed for use by pregnant women (Wang Weiyi, CN 1 778 1 99 of 05.3 1.2006), or for improving the microenvironment of the intestines of patients with hypoglycemia (Li Tao Zhao, CN1810161 patent of 08.02.2006). In the field of dermatological cosmetics, compositions containing selenium-rich yeast have been developed for the purpose of reducing hair damage (Kasik Heinz, DE 1 98 5 8670 of 06.2 1.2000) or preventing photoaging (Kawai Norihisa el al., JP07300409 patent of 11.14.1995). Medicinal preparations containing selenium-enriched yeast have been used to prevent and treat inflammatory conditions such as diabetic retinopathy (Crary Ely J., US Patent No. 5,623, 482 to 6.1 997), or cardiovascular inflammatory conditions (Nagy PL el al. , 09.28.1 992 of the HUT060436 patent). Bacteria and more particularly probiotics themselves are the subject of selenium enrichment (Calomme M. et al., Biol. Trace Elem. Res., 1 995, 47, 3 79-201107478 3 83 ). Lactobacillus acidophilus, reuteri lactic acid bacteria, ferintoshensis lactobacillus, buchn/parabuchneri lactobacillus (Andreoni V_al., US 02 58 964 patent) have been described as rich Selenium-containing food supplements. A mixture of probiotics from the yeast and lactobacilli groups (Huang Kehe Qin, 1 1.08.2006 CN 1 283 1 7 1 C patent) which has been prepared for the purpose of strengthening the immune system and disease resistance. However, in all of these formulations, the selenium-rich microorganisms were prepared only from machine selenium. Therefore, the most commonly used source of selenium consists of sodium selenite or sodium selenate which is stabilized in a microbial medium. Although a satisfactory amount of organic selenium which can be digested and absorbed by the human body has been synthesized, the selenium-rich micro-organism often has a high residual concentration of unconverted inorganic selenium, which has been confirmed to be dangerous to an individual who consumes. In the prior application disclosed in WO 2006/008 1 90, novel organic compounds of the hydroxy acid type have been described as precursors for the formation of L(+)-selenomethionine in humans and animals. Surprisingly, the Applicant has noted that selenoic acid type organic compounds, such as those described in the WO 2006/008 1 90 application, can be incorporated into a culture medium in which the polyphotosynthetic microorganism is enriched in organic selenium. The results obtained have revealed that these compounds are extremely efficient in making such microorganisms particularly rich in L(+)-selen thioglycolic acid, and the yield is equal to or even higher than that obtained using the inorganic compound generally used. Therefore, it has been shown that the use of selenic acid-type organic compounds to photosynthetically enriched organic selenium can produce organic selenium that does not contain inorganic selenium, and can also be produced by ΪΓ et 出生 出生 出生 彼 硒 硒 硒-8 - 201107478 Determine the toxicity issues associated with prior art methods. The selenium-rich photosynthetic microorganism can be directly used in food transactions for preventing or treating selenium deficiency, and is particularly suitable for the manufacture of pharmaceutical, nutraceutical or cosmetic products and compositions. SUMMARY OF THE INVENTION The present application relates to the acquisition of photosynthetic microorganisms, i.e., microorganisms grown in accordance with the source of light energy. The term "microorganism" attempts to identify any living single-cell organism that belongs to one of the following categories: monospores, unicellular organisms, molds, or protozoa, which have microscopic or ultramicroscopic eukaryotic or prokaryotic cellular structures. And he has metabolic and replication potential. These single cell microorganisms may be associated with the formation of fibrils or biofilms. Preferably, the photosynthetic microorganism according to the present invention is a eukaryotic microalgae, more preferably a Chlorella of the genus Chlorella; or a prokaryotic microalgae, such as a cyanobacteria, preferably a genus of the genus Aspergillus or Arthrospira ( Spirulina). The latter is customary for use as a food supplement for those skilled in the art, especially in developing countries. The term "organic selenium" is intended to indicate a collection of molecules containing a compound having at least one selenium atom in its chemical structure and capable of being produced by living tissue, particularly such as selenium methionine, methyl selenium cysteamine. An amino acid such as an acid or cysteine, or a peptide or protein containing the same. The selenium-rich photosynthetic microorganism itself can be used as a food additive. The latter may, for example, be dehydrated to form a stable powder which can be incorporated into the composition as a substrate for the preparation of the conversion product, but may also be used as a probiotic in the food conversion method by the method of -9 - 201107478. For the purpose of obtaining, for example, fermented milk or fake products. The subject matter of the present invention is therefore a novel method for enriching photosynthetic microorganisms with selenium methionine and/or selenocysteine, characterized in that the photosynthetic microorganism is cultured in a culture medium containing a selenoic acid type compound. Preferably, the selenoic acid type compound is a compound of the formula (I), or a precursor, a salt or an ester thereof or a guanamine derivative:

在該式中: η等於0、1或2 ; 1^是011、OCOR3、OP03H2、0P03R4R5 或 OR6 基團; R2是OH、R3、NHR7、S-半胱胺醯基或S-穀胱甘肽基 基團;應了解:當n=l且尺2是011時,R!不能是OH; R3是烷氧基、神經醯胺1、神經醯胺2、神經醯胺3、 神經醯胺4、神經醯胺5、神經醯胺6a及6b、S-半胱胺醯基 或S-穀胱甘肽基基團,或選自以下之基團: -10- 201107478In the formula: η is equal to 0, 1 or 2; 1^ is 011, OCOR3, OP03H2, 0P03R4R5 or OR6 group; R2 is OH, R3, NHR7, S-cysteamine thiol or S-glutathione Base group; it should be understood that when n=l and ruler 2 is 011, R! cannot be OH; R3 is alkoxy group, neuropterin 1, neural guanamine 2, neural guanamine 3, neural guanamine 4, Ceramide 5, ceramide 6a and 6b, S-cysteinyl thiol or S-glutathionyl group, or a group selected from the group consisting of: -10- 201107478

較佳地,r3是烷氧基、S-半胱胺醯基或S-穀胱甘肽基 基團; OR4是(C^-Cm )烷氧基基團、神經醯胺1、神經醯胺 2、神經醯胺3、神經醯胺4、神經醯胺5、神經醯胺6a及6b 、或選自以下之基團:Preferably, r3 is an alkoxy group, an S-cysteinyl sulfhydryl group or an S-glutathione group; OR4 is a (C^-Cm) alkoxy group, a ceramide, a ceramide 2. Neuropterin 3, neuropterin 4, neuropterin 5, neuropterin 6a and 6b, or a group selected from the group consisting of:

OKOK

-11 - 201107478 較佳地’ 0Κ·4是(C1-C26)院氧基基團; 〇R5是(CVC26 )烷氧基基團、神經醯胺1 '神經醯胺 2、神經醯胺3、神經醯胺4、神經醯胺5、神經醯胺6a及6b-11 - 201107478 Preferably, '0Κ·4 is a (C1-C26) alkoxy group; 〇R5 is a (CVC26) alkoxy group, a ceramide 1 'neoxime 2, a ceramide 3 Ceramide 4, neuropterin 5, neuropterin 6a and 6b

較佳地* OR5是(C1-C26)院氧基基團; 〇R6是丙酸根、乳酸根、檸檬酸根、反丁烯二酸根' 順丁烯二酸根、肉宣蔻酸根、棕櫚酸根、硬脂酸根、棕櫚 油酸根、油酸根或亞油酸根基團、天然脂肪酸基團或13_ 順式-視黃酸根(retinoate)基團; Κ·7是Η或(C1-C26)院基基團、天然胺基酸或天然月女 在以上式(I )中: - “院基”一詞意圖指明直鏈或環狀、任意分支、任意 氟化或多氟化之含有1至26個碳原子且任意地包含一或多 -12- 201107478 個碳一碳雙鍵之基團,例如甲基、乙基、異丙基、三氟甲 基、亞油基、亞麻基、或棕櫚酿基; _ “烷氧基”一詞意圖指明直鏈或環狀、任意分支、任 意氟化或多氟化之衍生自含有1至26個碳原子且任意地包 含一或多個碳-碳雙鍵之一級、二級或三級醇的基團,例 如甲氧基、乙氧基、異丙氧基、三氟甲氧基、亞油氧基、 亞麻氧基、或掠欄釀氧基; 一神經醯胺型之基團的結構特別經描述於“ Cosmetic Lipids and the Skin Barrier”,Thomas Forster Ed. 2002, M a r c e 1 D e k k e r,I n c.,第 2 頁圖 2 中; -“天然”一詞意圖指明在植物及動物界之組織的代謝 中及也在人類代謝中所發現的任何相關化合物(Steglich W., Rompp Encyclopedia Natural Products, G. Thieme ed. ); - “寡聚物”意圖指明藉由酯型鍵結互相連接之2至15 個單體的聯結所形成之任何化合物; 一“聚合物”意圖指明藉由酯型鍵結互相連接之多於15 個單體的聯結所形成之任何化合物。 依本發明,該式(I)化合物較佳以鈣鹽、鋅鹽或鎂 鹽形式被使用,該等形式通常能在培養介質中獲得更佳之 溶解性及由光合微生物之更佳的消化吸收。 在本發明之較佳具體實例中’該光合微生物係選自由 藍藻及綠藻所形成之族群中。因此’該光合微生物係有利 地選自藍藻或綠藻,較佳地選自由綠球藻屬之綠藻及螺旋 -13- 201107478 藻屬或節旋藻屬之藍藻所形成之族群中。 本發明更特別是關於選(或取)自以下之式(I )化 合物的用途: —L-2-羥基-4-甲基硒丁酸, 一 D-2-羥基-4-甲基硒丁酸, -DL-2-羥基-4-甲基硒丁酸, 或這些化合物之鹽。 這些化合物描述於WO 2006/008 1 90申請案中。 本發明之標的也是一種可依照本發明之方法獲得之富 含有機硒之光合微生物’。此種微生物在硒當量基礎上通常 具有大於500ppm,較佳地大於lOOOppm,更佳地大於 2〇00PPm之有機硒含量,及按該微生物乾重量少於0.5%, 較佳地少於0 · 2 %,且更佳地少於0 · 1 %的無機硒含量。較佳 地,本發明係關於光合微生物包含相對於總硒少於1 . 5 %, 較佳地少於0.5%,更佳地少於0.1 %之無機硒的情況。 換言之,在依本發明之方法富含硒之該光合微生物中 所存在之無機形式之硒殘餘物通常少於在該微生物中所存 在之總硒的1 . 5 %,此通常代表少於0.5 %之該微生物的總乾 生物質量(乾重量)。 本發明最特別地是關於一種富含有機硒之光合微生物 ,其特徵在於該微生物之硒甲硫胺酸形式的硒含量,相對 於在該光合微生物中所存在之總硒,是多於5 0質量%,較 佳地多於7 0質量%,更佳地多於8 0質量%,且甚至更佳地 多於90質量%的硒。就該微生物中所存在之有機硒的量及 -14- 201107478 品質而言’與先前技藝中所得者相比,此種硒甲硫胺酸的 比例代表一種顯著且特別有利的改良。 特別地’本發明係關於以下情況:該微生物特徵在於 彼是富含硒之綠藻微藻類,較佳是綠藻屬者,且特徵在於 該微生物含有按該微生物之乾重量計通常大於50微克硒當 量/克(AgSe/g),較佳地大於7〇AgSe/g,且更佳地大 於 100 〆 gSe/g 〇 ^ 經固定於該微生物內之有機分子型(硒甲硫胺酸、硒 半胱胺酸及類似者)或無機分子型(硒鹽類)之硒的量以 硒質量/克(y gSe/g )該微生物乾重量表示。換言之, 光合微生物之硒含量藉由計算在這些有機或無機分子中所 存在之硒質量而確立且回溯其與該微生物之總乾生物質量 的關係。此外,呈有機及無機型之硒的質量比例也被確立 且以相對於總硒質量的百分率表示。 依本發明之光合微生物之總硒及硒甲硫胺酸型之硒的 〇 ^ 含量可以藉由在該微生物之離心及凍乾後分別礦化及酶消 化測定,例如藉由遵循Lobinsky el al·,在Mester,Z. et al. (2006) Annal. Bioanal. Chem. 3 85: 1 68- 1 80 中所述之 方法。 在本申請案之實例中所說明之依本發明所得之結果顯 示:光合微生物(更特別是綠藻及藍藻微藻類)累積硒甲 硫胺酸形式之硒,其含量按這些微藻類之乾重量計通常大 於1〇〇微克硒當量/克(#gSe/g),較佳地大於200//gSe/g ,更佳地大於500/zgSe/g,甚至更佳地大於1000/zgSe/g, -15- 201107478 且甚至大於1400 // gSe/g。 本發明因此更特別地關於富含有機硒之綠藻或藍藻’ 其特徵在於其硒甲硫胺酸形式之有機硒含量按乾重量計通 常大於100微克硒當量/克(ygSe/g) ’較佳地大於200 //gSe/g,更佳地大於500;zgSe/g,甚至更佳地大於1〇〇〇 // gSe/g。 此種富含有機硒之綠藻及藍藻通常特徵在於:其硒甲 硫胺酸形式之有機硒含量是多於其所含之總硒的50% ’較 佳地多於7 〇 %,更佳地多於8 〇 %,甚至更佳地多於9 0 % ’且 甚至多於95 %,且也特徵在於其之殘餘無機硒含量是少於 其所含之總硒的1 . 5 %,較佳地少於〇 . 5 %,更佳地少於1 % 。通常,其之殘餘無機硒含量按重量計是少於該綠藻之總 生物質量的1 %,較佳地少於〇 · 5 %,更佳地少於0.2 %,且 甚至少於〇 . 1 %。 本發明也關於依本發明之方法由富含硒之光合微生物 製造食品、化妝品或醫藥產品。此種製造使用精於此技藝 者已知的技術。 依本發明之光合微生物也可以用在動物營養品中,特 別是供獲得富含有機硒之二次衍生物,例如魚、奶或蛋, 的目的。 因此所得之衍生產品及分子是用於多種應用,包括在 前文中摘述者,特別是作爲化妝、醫藥或營養用劑。 本發明之標的也是依本發明之富含硒之光合微生物作 爲化妝品、醫藥(或治療)或營養產品(劑)的用途。 -16- 201107478 本發明也關於包含該光合微生物之組成物,通常是化 妝、醫藥或營養組成物。 本發明也關於一種用於光合微生物之培養介質,其特 徵在於彼包含一或多種如以上定義之式(I)化合物。此 種培養介質具有實施依本發明之使光合微生物富含硒之方 法的用途。 特別地,本發明係關於一種固態或液態培養介質,其 Ο 包含至少一種式(I)化合物,較佳是2_羥基-4-甲基硒丁 酸或其鹽,濃度在0.5及2000 mg/1之間,較佳在1及1〇〇〇 mg/1之間,更佳在2及500 mg/1之間,亦即在硒當量基礎上 分別約在0.2及800 mg/1之間的該化合物,較佳在硒當量基 礎上在0.4及400 mg/1之間的該化合物,更佳在硒當量基礎 上在〇· 8及200 mg/1之間的該化合物。 對於源於海水之微藻類而言,式(I )化合物可以在 消毒過濾之海水中或在合成海水(例如由Aquarium O Systems Inc.,公司之“Reef Crystal”介質所製造的)中稀釋 以形成最低必需培養介質。 製備依本發明之微藻類的方法特別可以包含一或多個 以下步驟: -製備含有微藻生長所需之所有化學元素的培養介質 ,較佳是最低必需介質(minimum medium ); 一將式(I)化合物,較佳是2-羥基-4-甲基硒丁酸導 入該培養介質中作爲有機硒來源; 一將該混合物之pH調節成在6及10之間的値; -17- 201107478 -將在由此形成之混合物中培養之該微藻類的預培養 物的接種體放置於12及45 °C之間的溫度下,於可含有0至 20 %氧及0.3 %至20 %二氧化碳之氣體中較佳24至120小時並 加以 100 至 500rpm 的軌道搖盪(orbital shaking); —在4000及10 〇〇〇 rpm下將該混合物離心數分鐘,或 經由0.2微米濾器過濾該混合物且以生理食鹽水清洗過該 濾器; _細胞九浸入生理食鹽水中; -再次於4000及lOOOOrpm下離心數分鐘; -回收含有該富含硒之微藻類的潮濕細胞九。 該潮濕細胞九可經凍乾或空氣乾燥。 在以下實例中給予本發明之其他特徵及優點。下文中 之實例被提供以僅作爲說明且不能以任何方式限制本發明 之範圍。 【實施方式】 實例1 :在自營條件下在含有2-羥基-4-甲基硒丁酸(THD-177 )的介質中製造富含硒之綠球藻微藻 實驗條件 在光自營條件下所用之菌株是綠球藻SAG211-11B : 一種源自the University of G6ttingen之SAG收集的無寄生 物的囷株(SAG : Sammlung von Algenkulturen der Universitat Gottingen [Collection of Alga Cultures of the -18- 201107478Preferably *OR5 is a (C1-C26) alkoxy group; 〇R6 is propionate, lactate, citrate, fumarate's maleate, butanthate, palmitate, hard a fatty acid, palm oleate, oleate or linoleate group, a natural fatty acid group or a 13-cis-retinoate group; Κ·7 is a ruthenium or (C1-C26) aristocratic group, A natural amino acid or natural moon female in the above formula (I): - the term "hospital base" is intended to mean a straight or cyclic, arbitrary branch, any fluorinated or polyfluorinated one containing from 1 to 26 carbon atoms Any group optionally comprising one or more -12-201107478 carbon-carbon double bonds, such as methyl, ethyl, isopropyl, trifluoromethyl, linoleyl, linoleyl, or palmitic; _" The term "alkoxy" is intended to indicate that a straight chain or a ring, any branch, any fluorination or polyfluorination is derived from a group containing from 1 to 26 carbon atoms and optionally containing one or more carbon-carbon double bonds. a group of a secondary or tertiary alcohol such as methoxy, ethoxy, isopropoxy, trifluoromethoxy, linoleyloxy, linoleyloxy, or granule The structure of a thiol group; a structure of a neurosteroid type is described in particular in "Cosmetics Lipids and the Skin Barrier", Thomas Forster Ed. 2002, M arce 1 D ekker, I n c., Figure 2 on page 2 - The term "natural" is intended to indicate any related compound found in the metabolism of tissues in the plant and animal kingdoms and also in human metabolism (Steglich W., Rompp Encyclopedia Natural Products, G. Thieme ed.); - " "Oligomer" is intended to indicate any compound formed by the association of 2 to 15 monomers interconnected by an ester type linkage; a "polymer" is intended to indicate more than 15 single sheets interconnected by an ester type linkage Any compound formed by the association of the body. According to the present invention, the compound of the formula (I) is preferably used in the form of a calcium salt, a zinc salt or a magnesium salt, which forms a better solubility in a culture medium and a better digestion and absorption by a photosynthetic microorganism. In a preferred embodiment of the invention, the photosynthetic microorganism is selected from the group consisting of cyanobacteria and green algae. Thus, the photosynthetic microorganism is advantageously selected from the group consisting of cyanobacteria or green algae, preferably selected from the group consisting of the green algae of the genus Chlorella and the cyanobacteria of the genus Algae or Arthrospira. The invention more particularly relates to the use of a compound of formula (I) selected below: -L-2-hydroxy-4-methylselenobutyric acid, a D-2-hydroxy-4-methylselenidine Acid, -DL-2-hydroxy-4-methylselenobutyric acid, or a salt of these compounds. These compounds are described in the WO 2006/008 1 90 application. The subject matter of the invention is also a photosynthetic microorganism enriched with selenium which can be obtained in accordance with the method of the invention. Such microorganisms typically have an organic selenium content of greater than 500 ppm, preferably greater than 1000 ppm, more preferably greater than 2 00 ppm, based on selenium equivalents, and less than 0.5% by dry weight of the microorganism, preferably less than 0. %, and more preferably less than 0.1% inorganic selenium content. Preferably, the invention relates to the case where the photosynthetic microorganism comprises less than 1.5%, preferably less than 0.5%, more preferably less than 0.1% of inorganic selenium relative to total selenium. In other words, the selenium residue in the inorganic form present in the photosynthetic microorganism enriched in selenium in accordance with the process of the present invention is typically less than 1.5% of the total selenium present in the microorganism, which typically represents less than 0.5%. The total dry biomass (dry weight) of the microorganism. The invention particularly relates to a photosynthetic microorganism enriched in organic selenium, characterized in that the selenium content of the selenium methionine form of the microorganism is more than 50 relative to the total selenium present in the photosynthetic microorganism. The mass%, preferably more than 70% by mass, more preferably more than 80% by mass, and even more preferably more than 90% by mass of selenium. The ratio of such selenium methionine represents a significant and particularly advantageous improvement in terms of the amount of organic selenium present in the microorganism and the quality of -14-201107478 as compared to those obtained in the prior art. In particular, the present invention relates to the case where the microorganism is characterized in that it is a selenium-rich green algae microalgae, preferably a green algae, and is characterized in that the microorganism contains usually more than 50 micrograms based on the dry weight of the microorganism. Selenium equivalent / gram (AgSe / g), preferably greater than 7 〇 AgSe / g, and more preferably greater than 100 〆 gSe / g 〇 ^ organic molecular type fixed in the microorganism (selen methionine, selenium The amount of selenium in the cysteine and the like or the inorganic molecular type (selenium salt) is expressed in terms of selenium mass/gram (y gSe/g) of the dry weight of the microorganism. In other words, the selenium content of the photosynthetic microorganism is established by calculating the quality of the selenium present in these organic or inorganic molecules and retrospectively correlates it with the total dry biomass of the microorganism. In addition, the mass ratio of selenium in organic and inorganic forms is also established and expressed as a percentage relative to the total selenium mass. The total selenium of the photosynthetic microorganism according to the present invention and the selenium content of the selenium methionine type selenium can be determined by mineralization and enzymatic digestion after centrifugation and lyophilization of the microorganism, for example, by following Lobinsky el al· The method described in Mester, Z. et al. (2006) Annal. Bioanal. Chem. 3 85: 1 68- 1 80. The results obtained according to the present invention as illustrated in the examples of the present application show that photosynthetic microorganisms (more particularly green algae and cyanobacteria microalgae) accumulate selenium in the form of selenium methionine at a dry weight of these microalgae. Typically greater than 1 〇〇 microgram selenium equivalent per gram (#gSe/g), preferably greater than 200//g Se/g, more preferably greater than 500/zgSe/g, even more preferably greater than 1000/zgSe/g, -15- 201107478 and even greater than 1400 // gSe/g. The invention therefore more particularly relates to organic selenium-rich green algae or cyanobacteria characterized by a selenium methionine form having an organic selenium content generally greater than 100 micrograms of selenium equivalent per gram (ygSe/g) on a dry weight basis. Preferably, it is greater than 200 //gSe/g, more preferably greater than 500; zgSe/g, and even more preferably greater than 1 〇〇〇//gSe/g. Such organic selenium-rich green algae and cyanobacteria are generally characterized in that the selenium methionine form has an organic selenium content of more than 50% of the total selenium contained therein, preferably more than 7%, preferably more preferably More than 8 〇%, even more preferably more than 90% 'and even more than 95%, and is characterized by a residual inorganic selenium content of less than 1.5% of the total selenium contained therein. The good land is less than 〇. 5 %, more preferably less than 1%. Usually, the residual inorganic selenium content thereof is less than 1% by weight of the total biomass of the green algae, preferably less than 〇·5%, more preferably less than 0.2%, and even less than 〇. %. The invention also relates to the manufacture of food, cosmetic or pharmaceutical products from selenium-rich photosynthetic microorganisms in accordance with the method of the invention. Such fabrication uses techniques known to those skilled in the art. The photosynthetic microorganisms according to the invention can also be used in animal nutrition, in particular for the purpose of obtaining secondary derivatives rich in organic selenium, such as fish, milk or eggs. The resulting derivatives and molecules are therefore used in a variety of applications, including those enumerated above, particularly as cosmetic, pharmaceutical or nutraceutical agents. The subject matter of the invention is also the use of a selenium-rich photosynthetic microorganism according to the invention as a cosmetic, pharmaceutical (or therapeutic) or nutritional product (agent). -16- 201107478 The invention also relates to a composition comprising the photosynthetic microorganism, usually a makeup, pharmaceutical or nutritional composition. The invention also relates to a culture medium for photosynthetic microorganisms characterized in that it comprises one or more compounds of formula (I) as defined above. Such a culture medium has the use of a method according to the present invention for enriching selenium by photosynthetic microorganisms. In particular, the present invention relates to a solid or liquid culture medium comprising at least one compound of the formula (I), preferably 2-hydroxy-4-methylselenobutyric acid or a salt thereof, at a concentration of 0.5 and 2000 mg/ Between 1 and preferably between 1 and 1 〇〇〇 mg/1, more preferably between 2 and 500 mg/1, that is, between about 0.2 and 800 mg/1 on a selenium equivalent basis. The compound, preferably between 0.4 and 400 mg/1 on a selenium equivalent basis, more preferably between 〇·8 and 200 mg/1 on a selenium equivalent basis. For microalgae derived from seawater, the compound of formula (I) can be diluted in sterile filtered seawater or in synthetic seawater (for example, manufactured by Aquarium O Systems Inc., the company's "Reef Crystal" media). Minimum necessary culture medium. The method for preparing the microalgae according to the invention may in particular comprise one or more of the following steps: preparing a culture medium containing all the chemical elements required for the growth of the microalgae, preferably a minimum medium; I) a compound, preferably 2-hydroxy-4-methylselenobutyric acid, is introduced into the culture medium as a source of organic selenium; and the pH of the mixture is adjusted to be between 6 and 10; -17-201107478 - The inoculum of the pre-culture of the microalgae cultured in the mixture thus formed is placed at a temperature between 12 and 45 ° C, and may be contained in a gas containing 0 to 20% oxygen and 0.3% to 20% carbon dioxide. Preferably, it is 24 to 120 hours and orbital shaking is performed at 100 to 500 rpm; - the mixture is centrifuged at 4000 and 10 rpm for several minutes, or the mixture is filtered through a 0.2 micron filter and treated with physiological saline. The filter was washed; _ cells were immersed in physiological saline; - centrifuged again at 4000 and 1000 rpm for several minutes; - wet cells containing the selenium-rich microalgae were recovered. The moist cells can be lyophilized or air dried. Other features and advantages of the invention are set forth in the examples which follow. The following examples are provided to illustrate and not to limit the scope of the invention in any way. [Examples] Example 1: Production of selenium-rich Chlorella sp. microalgae in a medium containing 2-hydroxy-4-methylselenobutyric acid (THD-177) under self-operating conditions The strain used is Chlorella sp. SAG211-11B: a parasitic-free strain collected from the SAG of the University of G6ttingen (SAG: Sammlung von Algenkulturen der Universitat Gottingen [Collection of Alga Cultures of the -18-201107478

University of Gottingen])。 此菌株在由[Stanley RY et al_ 1971 Bacteriol. Rev. 35 :17卜205]所述之BG-11介質(藍綠介質)中培養,該BG-1 1介質之組成如下(每升):University of Gottingen]). This strain was cultured in a BG-11 medium (blue-green medium) as described in [Stanley RY et al_1971 Bacteriol. Rev. 35:17, 205], and the composition of the BG-1 1 medium was as follows (per liter):

O o (1 ) NaN03 : 1.5 克 (2 ) K2HP〇4 : 0.04克 (3 ) MgS04 . 7H20 : 0.075 克 (4 ) CaCl2 · 2H20 : 0.036 克 (5 )檸檬酸:0.006克 (6 )檸檬酸鐵銨:0.006克 (7 ) EDTA-Na2 : 0.02克 (8 ) Na2C03 : 0.02 克 (9) 蒸餾水1.0升 (10) 微量元素之溶液:1毫升/升 H3B〇3 : 2.86 克O o (1 ) NaN03 : 1.5 g ( 2 ) K 2 HP 〇 4 : 0.04 g ( 3 ) MgS04 . 7H20 : 0.075 g ( 4 ) CaCl 2 · 2H20 : 0.036 g (5 ) citric acid : 0.006 g (6 ) ferric citrate Ammonium: 0.006 g (7) EDTA-Na2: 0.02 g (8) Na2C03: 0.02 g (9) 1.0 L of distilled water (10) Solution of trace elements: 1 ml / liter of H3B 〇 3 : 2.86 g

MnCI〗· 4H2〇 : 1.81 克 ZnS04 · 7H20 : 0.222克 Na2Mo04 . 2H2 : 0.39克 CuS〇4 · 5H2〇 : 0.08克MnCI〗 4H2〇 : 1.81 g ZnS04 · 7H20 : 0.222 g Na2Mo04 . 2H2 : 0.39 g CuS〇4 · 5H2〇 : 0.08 g

Co(N03)2 . 6H20 : 0.05 克 pH被調節成7.1且該介質在121°C壓熱15分鐘。 此菌株在25°C下24〇0 + /-200 Lux,在光自營條件下培 養2至7日並加以軌道搖蕩(80 rpm) ,ODinit66Gnm = 〇.〇5。 該菌株之〇D66Qnni在48小時內達到0.5。 -19- 201107478 培養條件 有機硒之來源,亦即2-羥基-4-甲基硒丁酸(THD-177 ,Tetrahedron S AS, France, CAS : 873660-49-2 )在硒當 量基礎上以0.5毫克/升及100毫升/升之間的濃度被投予 ,亦即分別是1.25毫克/升及250毫克/升之2-羥基-4-甲 基硒丁酸被投予。此含硒之化合物在該培養開始時僅一次 地被添加(亦即每100毫升培養物0.125毫克及25毫克之間 的量),或在規律之時間間隔下添加數次,間隔時間是在 6及24小時之間,該培養物已維持2至7曰。 實例2:在含2_羥基_4 -甲基硒丁酸(THD-177)之介質中 (依本發明之實例)或在含亞硒酸鈉之介質中(比較用實 例),在混營條件下(光及碳水化合物-葡萄糖存在於介 質中)製造富含硒之綠球藻微藻 在這些測試中,所用之菌株是綠球藻SAG21 1-11 B菌 株:一種源自 the University of Gdttngen 之 SAG 收集的無 寄生物的菌株(SAG: Sammlung von Algenkulturen derCo(N03)2 . 6H20 : 0.05 g The pH was adjusted to 7.1 and the medium was autoclaved at 121 ° C for 15 minutes. This strain was cultured at 25 °C for 24 〇 0 + /-200 Lux under light self-operating conditions for 2 to 7 days and orbital (80 rpm), ODinit66Gnm = 〇.〇5. The strain D66Qnni reached 0.5 in 48 hours. -19- 201107478 The source of organic selenium in culture conditions, namely 2-hydroxy-4-methylselenobutyric acid (THD-177, Tetrahedron S AS, France, CAS: 873660-49-2) is 0.5 based on selenium equivalent. Concentrations between mg/L and 100 ml/L were administered, i.e., 1.25 mg/L and 250 mg/L 2-hydroxy-4-methylselenobutyric acid, respectively. The selenium-containing compound is added only once at the beginning of the culture (ie, between 0.125 mg and 25 mg per 100 ml culture), or several times at regular intervals, at intervals of 6 The culture has been maintained for 2 to 7 weeks between 24 hours. Example 2: In a medium containing 2-hydroxy-4-methylselenobutyric acid (THD-177) (in accordance with an example of the present invention) or in a medium containing sodium selenite (comparative example), in a mixed camp Production of selenium-rich Chlorella microalgae under conditions (light and carbohydrate-glucose in medium). In these tests, the strain used was Chlorella sp. SAG21 1-11 B strain: one from the University of Gdttngen Parasitic-free strain collected by SAG (SAG: Sammlung von Algenkulturen der

Universitat Gottingen[Collection of Alga Cultures of thUniversitat Gottingen[Collection of Alga Cultures of th

University of Gottingen]) , 質中培養: 酵母萃取物...... 牛肉萃取物...... 色糖(tryptose) . . · F 6 S 0 4........ 其係在混營條件下於以下介 0.33 克 0.33 克 0.66 克 0.66毫克 -20- 201107478 葡萄糖........ 3.3克 蒸餾水........ 加至1 · 〇升 pH調節成7.2且該介質在121。〇下壓熱15分鐘。 有機硒之來源,亦即2 -羥基-4-甲基硒丁酸(THD-177 ’ Tetrahedron SAS,France,CAS : 873660-49-2 )在硒當 量基礎上以20毫克/升的濃度被投予,亦即50毫克/升之 2-羥基-4-甲基硒丁酸被投予。 無機硒之來源(NaSe,亞硒酸鈉)在硒當量基礎上以 20毫克/升的濃度被投予,亦即43.9毫克/升之亞硒酸鈉 被投予。 含硒之有機化合物在綠球藻菌株之指數成長期中(亦 即在接種後3日)僅一次地被添加。 供分析之樣品的製備 在接種7日後,該介質經由0.2微米Nalgene薄膜(Ref a-PES,直徑90毫米)被過濾,且該細胞滯留物以生理食 鹽水清洗。濕細胞質量被凍乾以供硒成分之分析(總硒、 硒甲硫胺酸及亞硒胺酸)。 綠球藻之硒成分的分析 在該樣品之礦化後,藉由偶合至質量偵測的ICP分析 總硒。在依照 Lobinsky el al·,於Mester, Z. et al. ( 2006) Annal. B i o an al · C h em. 3 8 5 : 1 6 8 - 1 8 0 中所述之方法酶消化 該樣品後,硒之物種形成藉由偶合至串聯的質量偵測之高 -21 - 201107478 效率液體層析來進行。 結果 以下表1指明在硒當量基礎上對於7日接種時間重複三 次所得之平均値。 表1 綠球藻微藻之硒成分分析 總硒 毫克硒/ 公斤生物質量 硒甲硫胺酸 毫克硒/ 公斤生物質量 硒(IV) 毫克硒/ 公斤生物質量 添加THD177 20毫克硒/升 1293±23 1274±109 (總硒之98.5%) 6±1 (總硒之0.4%) 添加NaSe 20毫克硒/升 144+5 29+2 (總硒之20%) 4.1±0.4 (總硒之2.7%) 對於以THD177或NaSe形式添加之相同劑量的硒(在 此情況中爲20 mgSe/Ι)而言,所得結果顯示: 一以THF177形式進行之添加比以NaSe形式進行之添 加有多9倍之總硒被偵測到; -以硒甲硫胺酸形式累積在細胞內之硒的濃度(利用 THD177之添加所得者)比利用NaSe形式之添加所得者高 44倍; -若該添加係以THD 1 77形式進行,則以硒甲硫胺酸 形式累積在細胞內之硒的濃度大體上達到細胞內硒化合物 型之100% ( 98.5% ):與之相比,利用NaSe者達到20%之 濃度; 一若該添加是THD 1 7 7則偵測到在總硒中僅0.4 %之S e -22- 201107478 (IV );但在添加NaSe之情況中在總硒中偵測到2.7%之Se (IV)。 實例3 :在自營條件下於含有2-羥基-4-甲基硒丁酸( THD1 77 )(依本發明之實例)的介質中或在含有亞硒酸 鈉(比較用實例)的介質中製造富含硒之鈍頂節螺藻微藻 在自營條件下於以下介質中培養鈍頂節螺藻(鈍頂節 螺澡之標準菌株—FLAMANT VERT®,18000 Bourges,University of Gottingen]) , Quality Culture: Yeast Extract... Beef Extract... Tryptose . . . F 6 S 0 4........ It is under the mixed conditions of 0.33 g 0.33 g 0.66 g 0.66 mg-20- 201107478 glucose........ 3.3 g distilled water........ Add to 1 · Soaring pH is adjusted to 7.2 and the medium is at 121. Press under the pressure for 15 minutes. The source of organic selenium, ie 2-hydroxy-4-methylselenobutyric acid (THD-177 'Tetrahedron SAS, France, CAS: 873660-49-2) was cast at a concentration of 20 mg/l on a selenium equivalent basis. To this, 50 mg/L of 2-hydroxy-4-methylselenobutyric acid was administered. The source of inorganic selenium (NaSe, sodium selenite) was administered at a concentration of 20 mg/liter on the basis of selenium equivalent, that is, 43.9 mg/liter of sodium selenite was administered. The selenium-containing organic compound was added only once in the exponential growth phase of the Chlorella strain (i.e., 3 days after inoculation). Preparation of sample for analysis After 7 days of inoculation, the medium was filtered through a 0.2 μm Nalgene film (Ref a-PES, diameter 90 mm), and the cell retentate was washed with physiological saline. Wet cell mass was lyophilized for analysis of selenium components (total selenium, selenium methionine and selenosine). Analysis of Selenium Composition of Chlorella After the mineralization of the sample, total selenium was analyzed by coupling to mass detection ICP. After enzymatic digestion of the sample according to the method described by Lobinsky el al., Mester, Z. et al. (2006) Annal. B io an al · C h em. 3 8 5 : 1 6 8 - 1 80 Selenium species formation is achieved by coupling to the tandem mass detection of the high-21 - 201107478 efficiency liquid chromatography. Results Table 1 below indicates the average enthalpy obtained by repeating the vaccination time three times on the basis of the selenium equivalent. Table 1 Selenium component analysis of Chlorella sp. microalgae Total selenium mg selenium / kg Biomass selenium methionine mg selenium / kg biomass selenium (IV) mg selenium / kg biomass added THD177 20 mg selenium / l 1293 ± 23 1274±109 (98.5% of total selenium) 6±1 (0.4% of total selenium) Add NaSe 20 mg selenium/liter 144+5 29+2 (20% of total selenium) 4.1±0.4 (2.7% of total selenium) For the same dose of selenium (in this case 20 mg Se/Ι) added in the form of THD177 or NaSe, the results obtained show that: the addition in the form of THF177 is 9 times more than the addition in the form of NaSe. Selenium was detected; - the concentration of selenium accumulated in the cell in the form of selenium methionine (obtained by the addition of THD177) is 44 times higher than that obtained by the addition of the NaSe form; - if the addition is THD 1 In the form of 77, the concentration of selenium accumulated in the cell in the form of selenium methionine is substantially 100% (98.5%) of the intracellular selenium compound type: in comparison with the concentration of 20% using NaSe; If the addition is THD 177, only 0.4% of the total selenium is detected in S e -22- 201107478 (IV); In the case of NaSe detected 2.7% of Se (IV) in the total selenium. Example 3: Under self-operating conditions in a medium containing 2-hydroxy-4-methylselenobutyric acid (THD1 77) (in accordance with an example of the invention) or in a medium containing sodium selenite (comparative example) Production of selenium-rich Spirulina platensis microalgae under the self-operating conditions in the following medium to culture S. serrata (FLAMANT VERT®, 18000 Bourges, the standard strain of the blunt-tip snail bath)

France -使用其他菌株3054-E0001獲得類似結果): 酵母萃取物...... 0.33克 牛肉萃取物...... 0.33克 色糖(tryptose ) · . . . 0_66克 F e S Ο 4......... 0.66 毫克 蒸餾水........ 加至1.0升 pH調節成7.2且該介質在121°C下壓熱15分鐘。 有機硒之來源,亦即2 -經基-4 -甲基硒丁酸(THD-177 ,Tetrahedron S AS, France, CAS : 8 73 660-49-2 )在硒當 量基礎上以25毫克/升的濃度被投予,亦即62·5毫克/升 之2-羥基-4-甲基硒丁酸被投予。 無機硒之來源(NaSe,亞硒酸鈉)在硒當量基礎上以 25毫克/升的濃度被投予,亦即54.4毫克/升之亞硒酸鈉 被投予。 含硒之有機化合物在接種鈍頂節螺藻菌株後立即(亦 -23- 201107478 即τ = ο ) —次地被添加。 用於分析之樣品的製備 在接種10日後,細胞九粒經由0.2微米之Nalgene薄膜 過濾,且細胞滯留物以生理食鹽水清洗。濕的細胞質量被 凍乾以供硒成分(總砸、砸甲硫胺酸及亞硒酸鈉)分析。 鈍頂節螺藻之硒成分分析 在樣品之礦化後,藉由偶合至質量偵測之ICP分析總 硒。在依照 Lobinsky el al·,於 Mester, Z. et al. ( 2006) Annal. Bioanal. Chem. 385: 168-180 中所述之方法酶消化 該樣品後,硒之物種形成藉由偶合至串聯的質量偵測之高 效率液體層析來進行。 結果 以下表2指明在硒當量基礎上對於1 〇日接種時間重複 三次所得的平均値。 表2 吨頂節螺藻微藻之硒成分分析 總硒 毫克硒/公斤 生物質量 硒甲硫胺酸 毫克硒/公斤 生物質量 硒(IV) 毫克硒/公斤 生物質量 添加THD177 25毫克硒/升 1431±68 1402147 (總硒之98%) 17.2±0.7 (總硒之1.2%) 添加NaSe 25毫克硒/升 177+2 13±3 (總硒之7%) 5.1土0.3 (總硒之2.9%) -24 - 201107478 對於以THD177或NaSe形式添加之相同劑量的硒(在 此情況中爲2 5 m g S e /1 )而言’所得結果顯示: —以THF177形式進行之添加比以NaSe形式進行之添 加有多8倍之總硒被偵測到; -以硒甲硫胺酸形式累積在細胞內之硒的濃度(利用 THD177之添加所得者)比利用NaSe形式之添加所得者高 108倍; -若該添加係以THD 177形式進行,則以硒甲硫胺酸 形式累積在細胞內之硒的濃度達到細胞內含硒之化合物型 的98% ;與之相比,利用NaSe者達到7%之濃度; —若該添加是THD177則偵測到在總硒中僅1.2%之Se (IV ):但在添加NaSe之情況中在總硒中偵測到2.9%之Se (IV)。 實例4:於含有2-羥基-4-甲基硒丁酸(THD177)(依本發 明之實例)的介質中製造富含硒之鈍頂節螺藻微藻 在這些測試中,所用之菌株是鈍頂節螺藻菌株( FLAMANT VERT®, 1 8000 Bourges, France)。比較先前實 例(實例3 )及新實驗之間的結果: -在實例3期間,依本發明之含硒THD-177之化合物的 添加係在接種鈍頂節螺藻菌株後立即一次地進行; —在新實驗中,依本發明之含硒THD-177之化合物的 添加係如實例2中在該鈍頂節螺藻之培養的指數期中進行 -25- 201107478 結果 以下表3指明在硒當量基礎上對於1 0日接種時間重複 三次所得的平均値。 表3 鈍頂節螺藻微藻之硒成分分析 鈍頂節螺藻微 藻之硒成分 分析 總硒 毫克硒/公斤 生物質量 硒甲硫胺酸/ 公斤生物質量 THD177 毫克硒/公斤 生物質量 硒(IV) 毫克硒/公斤 生物質量 在接種時添加 THD177 25毫克硒/升 1431±68 1402±47 (總硒之98%) 5±1 (總硒之0.35%) 17.2±0.7 (總硒之1.2%) 在指數期添加 THD177 25毫克硒/升 1274±16 1078±89 (總硒之85%) 11±2 (總硒之0.86%) 14±2 (總硒之1.1%) 結果顯示:與“在成長期之期間添加”的測試(更特別 地在指數期之期間)相比,在“在接種時添加”之測試中獲 得多12%之總硒及多30%之硒甲硫胺酸型之硒。此差異可 能是:與在另一測試(“在指數期中添加”)中者相比,在 “在接種時添加”測試中生物質量與該THD-177之間較長 的接觸時間的結果。 在二情況中,細胞內之硒(IV )濃度仍保持在總硒之 1 %的低濃度下。 -26-France - Similar results were obtained using other strains 3054-E0001): Yeast extracts... 0.33 grams of beef extract... 0.33 grams of colored sugar (tryptose) · . . . 0_66 grams of F e S Ο 4......... 0.66 mg of distilled water........ The pH was adjusted to 7.2 to 1.0 liter and the medium was autoclaved at 121 ° C for 15 minutes. The source of organic selenium, ie 2 -transmethyl-4 -methylselenobutyric acid (THD-177, Tetrahedron S AS, France, CAS : 8 73 660-49-2 ) is 25 mg / liter based on selenium equivalent The concentration was administered, i.e., 62. 5 mg/L of 2-hydroxy-4-methylselenobutyric acid was administered. The source of inorganic selenium (NaSe, sodium selenite) was administered at a concentration of 25 mg/liter on the basis of selenium equivalent, that is, 54.4 mg/liter of sodium selenite was administered. The selenium-containing organic compound was added immediately after inoculation with S. sinensis strain (also -23-201107478, ie, τ = ο). Preparation of sample for analysis After 10 days of inoculation, nine cells of the cells were filtered through a 0.2 μm Nalgene membrane, and the cell retentate was washed with physiological saline. The wet cell mass was lyophilized for analysis of the selenium components (total sputum, methionine and sodium selenite). Selenium Component Analysis of Spirulina platensis After the mineralization of the sample, total selenium was analyzed by coupling to mass detection ICP. After enzymatic digestion of the sample according to the method described by Lobinsky el al., Mester, Z. et al. (2006) Annal. Bioanal. Chem. 385: 168-180, selenium species formation by coupling to tandem Mass detection is performed by high efficiency liquid chromatography. Results Table 2 below indicates the average enthalpy obtained by repeating the inoculation time of 1 day on the basis of selenium equivalents three times. Table 2 Selenium component analysis of Spirulina platensis microalgae Total selenium mg selenium/kg biomass selenium methionine mg selenium/kg biomass selenium (IV) mg selenium/kg biomass added THD177 25 mg selenium/liter 1431 ±68 1402147 (98% of total selenium) 17.2±0.7 (1.2% of total selenium) Add NaSe 25 mg selenium/liter 177+2 13±3 (7% of total selenium) 5.1 soil 0.3 (2.9% of total selenium) -24 - 201107478 For the same dose of selenium added in the form of THD177 or NaSe (in this case 2 5 mg S e /1 ), the results obtained show that: - the addition in the form of THF 177 is carried out in the form of NaSe The addition of 8 times more total selenium was detected; - the concentration of selenium accumulated in the cell in the form of selenium methionine (the one obtained by the addition of THD177) was 108 times higher than that obtained by the addition of the NaSe form; If the addition is carried out in the form of THD 177, the concentration of selenium accumulated in the cell in the form of selenium methionine reaches 98% of the compound type of selenium in the cell; compared with 7% in the case of NaSe Concentration; - If the addition is THD177, only 1.2% of Se (IV ) in total selenium is detected: but NaS is added In the case of e, 2.9% of Se (IV) was detected in total selenium. Example 4: Production of selenium-rich Spirulina platensis microalgae in a medium containing 2-hydroxy-4-methylselenobutyric acid (THD177) (in accordance with an example of the invention). In these tests, the strain used was Spirulina platensis strain (FLAMANT VERT®, 1 8000 Bourges, France). Comparing the results between the previous examples (Example 3) and the new experiments: - During the example 3, the addition of the selenium-containing THD-177 compound according to the invention was carried out once after inoculation with the S. serrata strain; In the new experiment, the addition of the selenium-containing THD-177 compound according to the present invention was carried out as in Example 2 in the exponential phase of the cultivation of S. serrata. The results are as follows. Table 3 below indicates on the basis of selenium equivalents. The average enthalpy obtained was repeated three times for the 10 day vaccination time. Table 3 Selenium component analysis of Spirulina platensis microalgae Selenium component analysis of total algae selenium/kg biomass selenium methionine/kg biomass THD177 mg selenium/kg biomass selenium IV) mg selenium/kg biomass THD177 25 mg selenium/liter 1431±68 1402±47 (98% of total selenium) 5±1 (0.35% of total selenium) 17.2±0.7 (1.2% of total selenium) In the exponential phase, add THD177 25 mg selenium / liter 1274 ± 16 1078 ± 89 (85% of total selenium) 11 ± 2 (0.86% of total selenium) 14 ± 2 (1.1% of total selenium) Results show: During the "additional period of growth" test (more specifically during the expiration period), in the "addition at vaccination" test, get 12% more total selenium and 30% more selenium methionine type selenium. This difference may be the result of a longer contact time between the biomass and the THD-177 in the "add at inoculation" test compared to the one in the other test ("added in the exponential phase"). In both cases, the concentration of selenium (IV) in the cells remained at a low concentration of 1% of total selenium. -26-

Claims (1)

201107478 七、申請專利範圍: 1. 一種使光合微生物富含有機硒之方法’其特徵在於 該光合微生物係在包含硒羥酸型化合物的介質中培養’該 硒羥酸型化合物在該微生物之成長期間導入該培養介質中 〇 2. 如申請專利範圍第1項之方法,其中在自營條件下 進行該培養。 Ο 3.如申請專利範圍第2項之方法,其中該光合微生物 係選自由藍藻及綠藻所形成之族群,較佳選自由綠球藻屬 之綠藻及螺旋藻屬或節旋藻屬之藍藻所形成的族群。 4. 如申請專利範圍第1項之方法,其中在混營( mixotrophic)條件下進行該培養。 5. 如申請專利範圍第4項之方法,其中該光合微生物 是選自由綠藻所形成之族群,較佳是由綠球藻屬之綠藻所 形成之族群。 〇 ^ 6.如申請專利範圍第1項之方法,其中在雜營( heterotrophic)條件下進行該培養。 7.如申請專利範圍第1項之方法,其中該硒羥酸型化 合物是如下文定義之通式(I),或該化合物之先質、鹽 或酯或醯胺衍生物:201107478 VII. Patent application scope: 1. A method for enriching photosynthetic microorganisms with organic selenium, characterized in that the photosynthetic microorganism is cultured in a medium containing a selenohydroxy acid type compound, and the selenoic acid type compound grows in the microorganism The medium is introduced into the culture medium during the process. 2. The method of claim 1, wherein the cultivation is carried out under self-operating conditions. 3. The method of claim 2, wherein the photosynthetic microorganism is selected from the group consisting of cyanobacteria and green algae, preferably selected from the group consisting of Chlorella spp. and Spirulina or Arthrospira. The ethnic group formed by cyanobacteria. 4. The method of claim 1, wherein the cultivation is carried out under mixedotrophic conditions. 5. The method of claim 4, wherein the photosynthetic microorganism is selected from the group consisting of green algae, preferably a group formed by green algae of the genus Chlorella. 〇 ^ 6. The method of claim 1, wherein the cultivation is carried out under heterotrophic conditions. 7. The method of claim 1, wherein the selenoic acid type compound is of the formula (I) as defined below, or a precursor, a salt or an ester or a guanamine derivative of the compound: 其中: -27- 201107478 η示0、1或2 ; RJOH、OCOR3、0Ρ03Η2、0P03R4R5 或 OR6 基團; R2是OH、R3、NHR7、S-半胱胺醯基或S-穀胱甘肽基 基團; 據了解:當n=l且R2S〇H時,I不能是OH; R3是烷氧基、S-半胱胺醯基或S-穀胱甘狀基基團、或 選自以下之基團:Wherein: -27- 201107478 η shows 0, 1 or 2; RJOH, OCOR3, 0Ρ03Η2, 0P03R4R5 or OR6 group; R2 is OH, R3, NHR7, S-cysteamine sulfhydryl or S-glutathione group It is understood that when n=l and R2S〇H, I cannot be OH; R3 is an alkoxy group, an S-cysteinyl sulfhydryl group or an S-glutathione group, or a group selected from the group consisting of group: OR4是(C^-Cn)烷氧基基團,或選自以下之基團:OR4 is a (C^-Cn) alkoxy group, or a group selected from the group consisting of: -28- 201107478-28- 201107478 〇r6是丙酸根、乳酸根、檸檬酸根、反丁烯二酸根、 正丁烯二酸根、肉宣蔻酸根、棕櫚酸根、硬脂酸根、棕櫚 油酸根、油酸根或亞油酸根基團、天然脂肪酸基團或13-順式-視黃酸根(r e t i η 〇 a t e )基團; -29- 201107478 R7是Η或((^-(:26)烷基基團、天然胺基酸或天然胺 〇 8. 如申請專利範圍第7項之方法,其中該式(I)化合 物係選自: 一 L-2-羥基-4-甲基硒丁酸, _ D-2-羥基-4-甲基硒丁酸, —DL-2-羥基-4-甲基硒丁酸, 或這些化合物之鹽。 9. 如申請專利範圍第8項之方法,其中該式(I)化合 物是鈣鹽、鋅鹽或鎂鹽形式。 10·如申請專利範圍第1至9項之任一項的方法,其中 該光合微生物係選自由藍藻及綠藻所形成之族群,較佳選 自由綠球藻屬之綠藻及螺旋藻屬或節旋藻屬之藍藻所形成 的族群。 11. 一種富含有機硒之光合微生物,其可如先前申請 專利範圍之任一項的方法獲得。 12. 如申請專利範圍第11項之富含有機硒之光合微生 物,該光合微生物特徵在於該微生物之硒甲硫胺酸形式的 硒含量,相對於在該光合微生物中所存在之總硒,是多於 50質量%,較佳地多於7〇質量%,更佳地多於80%且甚至更 佳地多於90質量%之硒。 13. —種富含有機硒之綠藻,其特徵在於其之硒甲硫 胺酸形式的有機硒含量是多於其所含之硒總質量的5 〇%, 更佳地多於70%,更佳地多於80%且甚至更佳地多於90%。 -30- 201107478 14. 一種富含有機硒之綠藻,其特徵在於其之硒甲硫 胺酸形式的有機硒含量按乾重量計是大於200# gSe/g’較 佳地大於500y gSe/g,且更佳地大於1000// gSe/g。 1 5 .如申請專利範圍第1 3或1 4項之富含有機硒之綠藻 ,其之殘餘無機硒含量,相對於其所含之總硒’是少於2 質量%,較佳地少於1 . 5質量%,更佳地少於1質量%。 16. 如申請專利範圍第13或14項之富含有機硒之綠藻 ,其之殘餘無機硒含量,相對於該綠藻之總生物質量’按 乾重量計成爲少於0.5質量%,較佳地少於0.2質量%,更佳 地少於〇.1質量%之無機硒。 17. —種富含有機硒之藍藻,其特徵在於其之硒甲硫 胺酸形式的有機硒含量是多於其所含之硒總質量的’ 較佳地多於70%,更佳地多於80%,且甚至更佳地多於90% 〇 18. —種富含有機硒之藍藻,其特徵在於其之硒甲硫 胺酸形式的有機硒含量按乾重量計是大於2 00 /z gSe/g ’較 佳地大於500/z gSe/g,且更佳地大於1000/z gSe/g。 19. 如申請專利範圍第17或18項之富含有機硒之藍藻 ’其之殘餘無機硒含量,相對於其所含之總硒,是少於2 質量%,較佳地少於1 · 5質量%,更佳地少於1質量%。 2 0.如申請專利範圍第1 7或1 8項之富含有機硒之綠藻 ,其之殘餘無機硒含量,相對於該藍藻之總生物質量’按 乾重量計成爲少於〇.5質量%,較佳地少於〇·2質量%,更佳 地少於0.1質量%之無機硒。 -31 - 201107478 2 1 .如申請專利範圍第1 7或1 8項之藍藻,其屬於螺旋 藻屬或節旋藻屬。 22· —種如申請專利範圍第11至21項中任一項的富含 有機硒的光合微生物作爲化妝品、藥品及營養劑的用途。 23 · —種組成物,其包含至少一種如申請專利範圍第 11至21項中任一項的富含有機硒的光合微生物。 2 4 ·如申請專利範圍第2 3項之組成物,其中該組成物 是化妝品、藥品或營養品。 -32- 201107478 四、指定代表圖: (一) 本案指定代表圖為:無。 (二) 本代表圖之元件符號簡單說明:無 ❹ 201107478 五、本案若有化學式時,請揭示最能顯示發明特徵的化學 式:無〇r6 is propionate, lactate, citrate, fumarate, methacrylate, nitrite, palmitate, stearate, palmitolate, oleate or linoleate, natural Fatty acid group or 13-cis-retinylate (reti η 〇ate ) group; -29- 201107478 R7 is hydrazine or ((^-(:26)alkyl group, natural amino acid or natural amine 〇 8. The method of claim 7, wherein the compound of formula (I) is selected from the group consisting of: L-2-hydroxy-4-methylselenobutyric acid, _D-2-hydroxy-4-methyl selenium Butyric acid, DL-2-hydroxy-4-methylselenobutyric acid, or a salt of these compounds. 9. The method of claim 8, wherein the compound of formula (I) is a calcium salt, a zinc salt or The method of any one of claims 1 to 9, wherein the photosynthetic microorganism is selected from the group consisting of cyanobacteria and green algae, preferably selected from the group consisting of Chlorella spp. a group formed by cyanobacteria or cyanobacteria of the genus Arthrospira 11. A photosynthetic microorganism rich in organic selenium, which can be patented as before A method of any of the scopes is obtained. 12. The photosynthetic microorganism characterized by the selenium methionine form of the microorganism, as compared to the photosynthetic organism in the selenium methionine form of the microorganism, as claimed in claim 11 The total selenium present in the microorganism is more than 50% by mass, preferably more than 7% by mass, more preferably more than 80% and even more preferably more than 90% by mass of selenium. A green algae containing selenium, characterized in that the selenium methionine form has an organic selenium content of more than 5%, more preferably more than 70%, more preferably more than 70%, more preferably 80% and even more preferably more than 90%. -30- 201107478 14. A green algae rich in organic selenium, characterized in that the content of organic selenium in the form of selenium methionine is greater than 200# by dry weight gSe/g' is preferably greater than 500 y gSe/g, and more preferably greater than 1000//gSe/g. 15. The organic selenium-rich green algae according to claim 13 or 14 of the patent application, The residual inorganic selenium content is less than 2% by mass, preferably less than 1.5% by mass, and more preferably less than the total selenium contained therein. 1% by mass. 16. The organic selenium-rich green algae according to claim 13 or 14 of the patent, the residual inorganic selenium content of which is less than 0.5 mass by dry weight relative to the total biomass of the green algae %, preferably less than 0.2% by mass, more preferably less than 0.1% by mass of inorganic selenium. 17. An organic selenium-rich cyanobacterium characterized by selenium methionine in the form of organic selenium The content is more than 70%, more preferably more than 80%, and even more preferably more than 90% of the total mass of selenium contained therein. It is characterized in that the selenium methionine form has an organic selenium content of more than 200 / z gSe / g ', preferably more than 500 / z gSe / g, and more preferably more than 1000 / z gSe / on a dry weight basis g. 19. The residual inorganic selenium content of the organic selenium-rich cyanobacteria as claimed in claim 17 or 18 is less than 2% by mass, preferably less than 1.25, relative to the total selenium contained therein. % by mass, more preferably less than 1% by mass. 2 0. If the organic selenium-rich green algae of claim No. 17 or 18 of the patent application, the residual inorganic selenium content of the cyanobacteria is less than 〇.5 by dry weight. %, preferably less than 2% by mass, more preferably less than 0.1% by mass of inorganic selenium. -31 - 201107478 2 1. A cyanobacteria as claimed in claim 17 or 18, belonging to the genus Spirulina or Arthrospira. 22. The use of an organic selenium-rich photosynthetic microorganism as claimed in any one of claims 11 to 21 as a cosmetic, pharmaceutical and nutraceutical. A composition comprising at least one organic selenium-rich photosynthetic microorganism according to any one of claims 11 to 21. 2 4 . The composition of claim 23, wherein the composition is a cosmetic, pharmaceutical or nutritional product. -32- 201107478 IV. Designated representative map: (1) The representative representative of the case is: None. (2) A brief description of the symbol of the representative figure: None ❹ 201107478 V. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: none -4--4-
TW099119944A 2009-08-28 2010-06-18 Photosynthetic microorganisms enriched in selenium using selenohydroxy acid compounds, uses thereof in nutrition, cosmetics and pharmacy TWI495725B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FR2009/001044 WO2010023384A1 (en) 2008-08-29 2009-08-28 Photosynthetic microorganisms enriched in selenium using selenohydroxy acid compounds, uses thereof in nutrition, cosmetics and pharmacy

Publications (2)

Publication Number Publication Date
TW201107478A true TW201107478A (en) 2011-03-01
TWI495725B TWI495725B (en) 2015-08-11

Family

ID=44838247

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099119944A TWI495725B (en) 2009-08-28 2010-06-18 Photosynthetic microorganisms enriched in selenium using selenohydroxy acid compounds, uses thereof in nutrition, cosmetics and pharmacy

Country Status (1)

Country Link
TW (1) TWI495725B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202272B (en) * 1988-02-09 1991-02-28 Caola Kozmetikai Process for producing algae
FR2873376B1 (en) * 2004-07-23 2006-11-24 Tetrahedron Sas NOVEL SELENO-HYDROXYACIDS AND DERIVATIVES, NUTRITION APPLICATIONS, COSMETICS AND PHARMACY

Also Published As

Publication number Publication date
TWI495725B (en) 2015-08-11

Similar Documents

Publication Publication Date Title
JP5855939B2 (en) Photosynthetic microorganisms enriched with selenium using selenohydroxy acid compounds and their use in nutritional foods, cosmetics and medicines
JP5517215B2 (en) Fermentation and culture method, plant fermented extract, plant fermented extract powder and blended plant fermented extract
CN102618452B (en) Preparation method, composition and application of lactobacillus salivarius and its metabolites
CN115322932B (en) Lactobacillus plantarum with anti-alcohol and sobering-up capabilities and application thereof
KR101703909B1 (en) Non-photosynthetic micro-organisms enriched with organic selenium from seleno-hydroxyacid compounds, and applications thereof in the fields of nutrition, cosmetics, and pharmaceuticals
CN106544287A (en) One plant of moral formula lactobacillus with oxidation resistance and bacteriocinogeny
CN113209141B (en) Composition based on brown algae extract and lactobacillus reuteri and application thereof
TWI495725B (en) Photosynthetic microorganisms enriched in selenium using selenohydroxy acid compounds, uses thereof in nutrition, cosmetics and pharmacy
Kiatpapan et al. Production of 5-aminolevulinic acid by Propionibacterium acidipropionici TISTR442
CN112400760B (en) Method for relieving transportation stress of freshwater fishes
TWI358266B (en)
WO2017216818A1 (en) Anaerobic growth of bacteria in unicellular alga
CN115960767A (en) Lactobacillus plantarum and application thereof
CN117050909A (en) Probiotic fermented product for sobering up and detoxifying and application thereof

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees